(Eddy Kennedy/CBC)Crystal and his colleagues came up with a naloxone nasal spray, intended to be more appealing and easier to administer than prefilled injectors or the other naloxone alternatives. Crystal's California-based Opiant Pharmaceuticals Inc. partnered with Irish company Adapt Pharma to market the spray version under the brand name Narcan. Having a simple to use, reliable, FDA-approved nasal spray was extremely desirable. Once you have a nasal spray, you open up a huge patient population and bystander population who are now willing and able to use it. You want them to be committed to using Narcan nasal spray.

Source: CBC News January 01, 2018 16:18 UTC